These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21619894)

  • 1. Rapid screening and confirmatory methods for biochemical diagnosis of human prion disease.
    Ugnon-Café S; Dorey A; Bilheude JM; Streichenberger N; Viennet G; Meyronet D; Maues de Paula A; Perret-Liaudet A; Quadrio I
    J Virol Methods; 2011 Aug; 175(2):216-23. PubMed ID: 21619894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.
    Hill AF; Butterworth RJ; Joiner S; Jackson G; Rossor MN; Thomas DJ; Frosh A; Tolley N; Bell JE; Spencer M; King A; Al-Sarraj S; Ironside JW; Lantos PL; Collinge J
    Lancet; 1999 Jan; 353(9148):183-9. PubMed ID: 9923873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of the diagnostic tools.
    Coste J
    Transfus Clin Biol; 2013 Sep; 20(4):412-5. PubMed ID: 23928182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid diagnosis of human prion disease using streptomycin with tonsil and brain tissues.
    Quadrio I; Ugnon-Café S; Dupin M; Esposito G; Streichenberger N; Krolak-Salmon P; Vital A; Pellissier JF; Perret-Liaudet A; Perron H
    Lab Invest; 2009 Apr; 89(4):406-13. PubMed ID: 19188908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry.
    Dabaghian RH; Barnard G; McConnell I; Clewley JP
    J Virol Methods; 2006 Mar; 132(1-2):85-91. PubMed ID: 16219367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and limits of TSE diagnostic tools.
    Grassi J; Maillet S; Simon S; Morel N
    Vet Res; 2008; 39(4):33. PubMed ID: 18284910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of non-prion biomarkers for the diagnosis of Transmissible Spongiform Encephalopathies in the live animal.
    Parveen I; Moorby J; Allison G; Jackman R
    Vet Res; 2005; 36(5-6):665-83. PubMed ID: 16120244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnostic tools in Creutzfeldt-Jakob disease and other prion disorders.
    Van Everbroeck B; Boons J; De Leenheir E; Lübke U; Cras P
    Expert Rev Mol Diagn; 2004 May; 4(3):351-9. PubMed ID: 15137902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of ruminant transmissible spongiform encephalopathy isolate types, including bovine spongiform encephalopathy and CH1641 scrapie.
    Jacobs JG; Sauer M; van Keulen LJ; Tang Y; Bossers A; Langeveld JP
    J Gen Virol; 2011 Jan; 92(Pt 1):222-32. PubMed ID: 20943889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting.
    Ritchie DL; Head MW; Ironside JW
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):360-8. PubMed ID: 15305981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for the development of pre-mortem laboratory diagnostic tests for Creutzfeldt-Jakob disease.
    Dabaghian RH; Mortimer PP; Clewley JP
    Rev Med Virol; 2004; 14(6):345-61. PubMed ID: 15495196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease.
    Herzog C; Rivière J; Lescoutra-Etchegaray N; Charbonnier A; Leblanc V; Salès N; Deslys JP; Lasmézas CI
    J Virol; 2005 Nov; 79(22):14339-45. PubMed ID: 16254368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple and specific detection of abnormal prion protein by a magnetic bead-based immunoassay coupled with laser-induced fluorescence spectrofluorometry.
    Kim JI; Wang C; Kuizon S; Xu J; Barengolts D; Gray PC; Rubenstein R
    J Neuroimmunol; 2005 Jan; 158(1-2):112-9. PubMed ID: 15589044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BSE: can we predict the future?
    Plum J
    Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA.
    Kang SC; Li R; Wang C; Pan T; Liu T; Rubenstein R; Barnard G; Wong BS; Sy MS
    J Pathol; 2003 Apr; 199(4):534-41. PubMed ID: 12635145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comments on present-day spread and epidemiology of BSE and prion diseases].
    Bodemer W; Kaup FJ
    Gesundheitswesen; 2004 Feb; 66 Suppl 1():S21-5. PubMed ID: 14770333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro bioassay systems for the amplification and detection of abnormal prion PrP(Sc) in blood and tissues.
    Zhang W; Wu J; Li Y; Carke RC; Wong T
    Transfus Med Rev; 2008 Jul; 22(3):234-42. PubMed ID: 18572098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubulovesicular structures are a consistent (and unexplained) finding in the brains of humans with prion diseases.
    Liberski PP; Sikorska B; Hauw JJ; Kopp N; Streichenberger N; Giraud P; Budka H; Boellaard JW; Brown P
    Virus Res; 2008 Mar; 132(1-2):226-8. PubMed ID: 18164506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.